Biotech Rally Creates Fertile M&A Ground for Small Caps: OncoSec Medical Inc....
By AlphaVN While I am not personally a huge fan of high risk, high cost-of-capital businesses, I tend to spend a lot of time writing about them. Mining and high-tech are two of the highest...
View ArticlePharmacy Alliances and the Need for Niche Providers: APHY, WAG, ABC, BIOS,...
By AlphaVN With the upcoming overhaul of the U.S. health care market, known as the Affordable Care Act – that’s ObamaCare in common political parlance – it is expected that there will be a drive...
View ArticleArena Pharmaceuticals, Inc. (NASDAQ:ARNA): Belviq Pre-Launch Analysis
By Spencer Osborne The long anticipated launch of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) anti-obesity drug is upon us. On Friday, June 7th, Arena and marketing partner Eisai Co., Ltd. (ESALY) will...
View ArticleCan Stevia Help Soft Drinks Get Past the Obesity and Diabetes Epidemic?...
By Craig Keolanui The worldwide addiction to sugary sweet carbonated beverages has taken its toll on an adoring public, and health experts are starting to raise red flags. Obesity and type-II diabetes...
View ArticleArena Pharmaceuticals, Inc. (NASDAQ:ARNA) and VIVUS, Inc. (NASDAQ:VVUS): Web...
By Spencer Osborne Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and VIVUS, Inc. (NASDAQ:VVUS) both make an anti-obesity product that is on the market. Vivus launched its drug Qsymia last Fall, while Arena...
View ArticleIs Sodastream International (NASDAQ:SODA) Still An Attractive Buy?
By Phil Lassiter SodaStream International Ltd. (NASDAQ:SODA), a small Israeli company that produces affordable countertop home-based soda machines, continues its impressive run, up almost 80% over the...
View ArticleArena Pharmaceuticals (NASDAQ:ARNA) To Make First Post-Launch Presentation
By Spencer Osborne Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and marketing partner Eisai Co., Ltd. (ESALY) launched the anti-obesity drug, Belviq, on June 7th, 2013. Investors are eagerly awaiting some...
View ArticleWeekly Web Trends For Arena Pharmaceuticals (ARNA) And Vivus (VVUS)...
By Spencer Osborne Arena Pharmaceuticals’ (NASDAQ:ARNA) recent launch of the anti-obesity drug Belviq, joining VIVUS (NASDAQ:VVUS), the provider of Qsymia, we now have two companies and can see...
View ArticleAffordable Care Act Will Benefit Drugstores Treating Chronic Illnesses: APHY,...
By Yagmur Kurt Pharmacy stocks have been some of the best performers over the past two years, despite lower overall sales, due to an increase in newly available generics. For example, Costco Wholesale...
View ArticleInteresting Immunotherapy Cancer Stocks: AMGN, ONCS, VICL
By Stone Fox Capital Advisors As with any treatments dealing with cancer, opportunity exists to drastically improve the survival rates and, as importantly, reduce the side effects caused by surgery and...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS): Web...
By Spencer Osborne We are now entering a phase where Arena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS) are going head to head with the goal of trimming pounds off of the citizens of...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS):...
By Spencer Osborne The head to head battle for obesity pill supremacy is just heating up. Weekly script numbers are telling just part of the story. While the battle at the pharmacy gets the most...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS): Weekly...
By Spencer Osborne Once again it is time to look at the weekly web trends for Arena Pharmaceuticals’ (NASDAQ:ARNA) Belviq and Vivus’ (NASDAQ:VVUS) Qsymia. I post this data weekly as a reference for...
View ArticleSirius XM Radio (NASDAQ:SIRI): Maxim Group’s John Tinker Raises Price Target...
By Demian Russian Weighing in ahead of Sirius XM Radio’s (NASDAQ:SIRI) Q2 earnings release, scheduled for Thursday, July 25th, 2013, Maxim Group Senior Media Analyst John Tinker reiterates a BUY rating...
View ArticleChaz Bono Gives Weight Loss Drugs Celebrity Appeal — Arena Pharmaceuticals...
By Spencer Osborne Chaz Bono is famous for several reasons. First and foremost Chaz was born the child of Sonny and Cher. Secondly Chaz was famous for being transgender and undergoing a sex change...
View ArticleWhen Does A Reverse Stock Split Make Sense? (MARA, NOG, VHC, VRNG, AIG, CDE)
By Mobile Guru In the investing community, few things can get an investor’s attention faster than hearing the word “Reverse Split”. This is typically because reverse splits are more often than not...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS):...
By Spencer Osborne Once again it is time to look at the weekly web trends for Arena’s (ARNA) Belviq and Vivus’ (VVUS) Qsymia. I post this data weekly as a reference for investors. This week I will add...
View ArticleNeoStem Inc. (NYSEMKT:NBS): On the Leading Edge of the Advancement of Cell...
By Craig Keolanui Is stem cell therapy going to be to the biotechnology industry what Tesla Motors is to the automotive industry? Stem cell therapy has waited at the sidelines while investors pump...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and Anti-Obesity Drug Belviq: The...
By Spencer Osborne Ellie Wenker – Trial, Tribulation, Challenges, SUCCESS If you had the good fortune to wake up tomorrow and be whatever you wanted to be would you do it? You likely have a picture in...
View ArticleSirius XM Radio Inc. (NASDAQ:SIRI): RBC Capital Markets Global Media Analyst...
By Demian Russian With a new research report issued on the heels of Sirius XM Radio’s (NASDAQ:SIRI) second quarter earnings results and conference call, RBC Capital Markets Global Media Analyst David...
View Article
